Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-α, in cardio-pulmonary bypass

European Cytokine Network

Volumn 19, Issue 2, 2008, Pages 99-103

  Caorsi, Carlos ^a   Pineda, Fernando ^a   Munoz, Carlos ^b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

CPB; CRP; IL 6; Inflammation; Inflammatory mediators; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; DILTIAZEM; INTERLEUKIN 1; INTERLEUKIN 6; PRAVASTATIN; TUMOR NECROSIS FACTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMMUNOMODULATION; MALE; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; BIOSYNTHESIS; BLOOD; INFLAMMATION; METHODOLOGY; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME;

AGED; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PRAVASTATIN; RISK FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 55749101764     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0124     Document Type: Article

References (27)

1. Boyle EM, Pohlman TH, Johnson MC, et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997; 64: S31.
2. Kirklin JK, Westaby S, Blackstone EH, et al.Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845.
3. Utley JR. The immune response and cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR, eds. Principles and Practice of Cardiopulmonary Bypass. Baltimore, Md: Williams & Wilkins, 1993: 249.
4. Diegeler A, Doll N, Rauch T, et al. Humoral immune response during coronary artery bypasses grafting. Circulation 2000; 102(Suppl. III): 95.
5. Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315.
6. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000; 101: 1372.
7. Kinlay S, Selwyn A. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol 2003; 91(Suppl.): 9B.
8. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165.
9. Verma S, Wang CH, Li SH, etal. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913.
10. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383.
11. Ridker PM, Rifai N, Clearfield M, et al. Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959.
12. Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or ator vastatin evaluation and infection therapy-thrombolysis in myocar dial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495.
13. Florens E, Salvi S, Peynet J, et al. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. J Card Surg 2001; 16: 232.
14. Werba JP, Tremoli E, Massironi P, et al. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg 2003; 76: 2132.
15. Tsiara S, Elisaf M, Mikhailidis D. Early vascular benefits of statin therapy. Curr Med Res Opin 2003; 19: 540.
16. Brull DJ, Sanders J, Rumley A, et al. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol 2001; 88: 431.
17. Caorsi C, Quintana E, Valdes S, et al. Continuous cardiac output and hemodynamic monitoring: high temporal correlation between plasma TNF-alpha and hemodynamic changes during a sepsis-like state in cancer immunotherapy. J Endotoxin Res 2003; 9: 91.
18. Kinlay S, Schwartz GG, Olsson AG, et al. Myocardial schemia reduction with aggressive cholesterol lowering study investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003; 108: 1560.
19. Jialal I, Stein D, Balis D, et al. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001; 103: 1933.
20. Biasucci LM, Liuzzo G, Fantuzzi G, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in hospital coronary events. Circulation 1999; 99: 2079.
21. Fransen E, Maessen J, Dentener M, et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 113: 1290.
22. Massoudy P, Zahler S, Becker BF, et al. Evidence for inflammatory responses of the lungs during coronary artery bypasses grafting with cardiopulmonary bypass. Chest 2001; 119: 31.
23. Liakopoulos OJ, Dorge H, Schmitto JD, et al. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006; 54: 250.
24. Radaelli A, Loardi C, Cazzaniga M, Balestri G, et al. Inflammatory activation during coronary surgery and its dose-dependent modulation by statin/ACE-inhibition combination. Arteioscler Thromb Vasc Biol 2007; 12: 2750.
25. Walter DH. Insights into early and rapid effects of statin therapy. Curr Pharm Des 2004; 10: 369.
26. Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response alter coronary bypass surgery. Crit Care Med 2006; 34: 660
27. Chaney MA. Corticosteroids and cardiopulmonary bypass. A review of clinical investigations. Chest 2002; 121: 921.